Mixed effect models of longitudinal Alzheimer's disease data: a cautionary note.
暂无分享,去创建一个
[1] A. Kurz,et al. Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease , 1996, Neurology.
[2] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[3] T J Rosen,et al. Age at Onset and Rate of Progression of Alzheimer's Disease , 1987, Journal of the American Geriatrics Society.
[4] B. Winblad,et al. Apolipoprotein ϵ4 allele and disease progression in patients with late-onset Alzheimer's disease , 1995, Neuroscience Letters.
[5] J. Hughes,et al. Cognitive deterioration in Alzheimer's disease: behavioral and health factors. , 1990, Journal of gerontology.
[6] Nan M. Laird,et al. Using the General Linear Mixed Model to Analyse Unbalanced Repeated Measures and Longitudinal Data , 1997 .
[7] B T Hyman,et al. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease , 1996, Annals of neurology.
[8] E B Larson,et al. Head Circumference as a Measure of Cognitive Reserve , 1996, British Journal of Psychiatry.
[9] A. Heyman,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1993, Neurology.
[10] R. Brookmeyer,et al. Apolipoprotein E genotype and rate of decline in probabole Alzheimer's disease , 1996 .
[11] Yaakov Stern,et al. The absence of an apolipoprotein ϵ4 allele is associated with a more aggressive form of Alzheimer's disease , 1997, Annals of neurology.
[12] N. Cook,et al. Design and analysis methods for longitudinal research. , 1983, Annual review of public health.
[13] R. Brookmeyer,et al. Predicting Rate of Cognitive Decline in Probable Alzheimer's Disease , 1996, Brain and Cognition.
[14] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[15] Y. Stern,et al. Preliminary Findings from the Predictors Study: Utility of Clinical Signs for Predicting Disease Course , 1995, Alzheimer disease and associated disorders.
[16] P. Tiraboschi,et al. Rate of Progression and Prognostic Factors in Alzheimer's Disease: A Prospective Study , 1993, Journal of the American Geriatrics Society.
[17] E B Larson,et al. Cognitive decline in Alzheimer's disease: a longitudinal investigation of risk factors for accelerated decline. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.
[18] J. Becker,et al. Predictors of Decline in Alzheimer's Disease , 1991, Cortex.
[19] W. Markesbery,et al. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.
[20] K. Davis,et al. Deterioration on the blessed test in Alzheimer's disease: Longitudinal data and their implications for clinical trials and identification of subtypes , 1992, Psychiatry Research.
[21] Steven D. Edland,et al. Accelerated decline in apolipoprotein E-ϵ4 homozygotes with Alzheimer's disease , 1998, Neurology.
[22] R B Wallace,et al. Longitudinal application of cognitive function measures in a defined population of community-dwelling elders. , 1991, Annals of epidemiology.
[23] S. Corkin,et al. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease , 1996, Neurology.
[24] Anthony F Jorm,et al. Controlled and automatic information processing in senile dementia: a review , 1986, Psychological Medicine.
[25] E. Corder,et al. Apolipoprotein E Genotype and Rate of Decline in Probable Alzheimer's Disease , 1996 .
[26] K. Blennow,et al. Heterogeneity of the Course of Alzheimer's Disease: A Differentiation of Subgroups , 1991 .
[27] B. O’Donnell,et al. The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course. , 1990, Archives of neurology.
[28] M. Rossor,et al. Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. , 1995, American journal of medical genetics.
[29] M. Finch,et al. Predictors of cognitive and functional progression in patients with probable Alzheimer's disease , 1992, Neurology.
[30] J. Yesavage,et al. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. , 1997, The American journal of psychiatry.